Cost-effectiveness of cognitive behavioural therapy and selective serotonin reuptake inhibitors for major depression in children and adolescents.

OBJECTIVE: To assess from a health sector perspective the incremental cost-effectiveness of cognitive behavioural therapy (CBT) and selective serotonin reuptake inhibitors (SSRIs) for the treatment of major depressive disorder (MDD) in children and adolescents, compared to 'current practice'. METHOD...

Descripción completa

Detalles Bibliográficos
Publicado en:Australian & New Zealand Journal of Psychiatry Vol. 38; no. 8; pp. 579 - 592
Autores principales: Haby MM, Tonge B, Littlefield L, Carter R, Vos T
Formato: research systematic review tables/charts Journal Article
Publicado: Sage Publications Inc. Aug2004
Acceso en línea:Ver este registro en EBSCOhost